EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effect of DNA methylation at the CTLA4 gene on the clinical status of autoimmune thyroid diseases

Hiroki Ohtani, Naoya Inoue, Yoshinori Iwatani, Yuri Takeno, Yuya Arakawa, Yoh Hidaka, Mikio Watanabe

Clinical Immunology · 2024

DOI: 10.1016/j.clim.2024.110338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2024. Verfasst von Hiroki Ohtani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Yamadaoka 1-7 Suita, Osaka 565-0871, Japan. Hauptthemen laut MEDLINE: CTLA-4 Antigen, DNA Methylation, Graves Disease, Hashimoto Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JSPS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pathogenesis and manifestation of autoimmune thyroid diseases (AITDs), Graves' disease (GD), and Hashimoto's disease (HD) are associated with T cell activation. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) plays a crucial role in the regulation of T cell activation. DNA methylation levels of eight CpG sites in the CTLA4 gene and expression levels of soluble CTLA-4 were examined. Methylation levels of +22 CpG and CT60 CpG-SNPs in patients with GD and HD with the CT60 GG genotype were lower than those in control subjects. Methylation levels of the-15 CpG sites were lower in patients with intractable GD than those in GD patients in remission. These results suggest that demethylation of +22 CpG and CT60 CpG-SNPs may be associated with susceptibility to GD and HD in subjects with the CTLA4 CT60 GG genotype, and that demethylation of -15 CpG may be associated with the intractability of GD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CTLA-4 AntigenDNA MethylationGraves DiseaseHashimoto DiseaseAdultAgedFemaleHumansMaleMiddle AgedYoung AdultCpG IslandsGenetic Predisposition to DiseaseGenotypePolymorphism, Single Nucleotide

Stichwörter der Autor:innen

Autoimmune thyroid diseaseCTLA-4MethylationSeveritySingle nucleotide polymorphism

Substanzen

CTLA-4 AntigenCTLA4 protein, human

Autor:innen und Institutionen

  • Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Yamadaoka 1-7 Suita, Osaka 565-0871, Japan.
  • Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Yamadaoka 1-7 Suita, Osaka 565-0871, Japan; Laboratory for Clinical Investigation, Osaka University Hospital, Yama…
  • Laboratory for Clinical Investigation, Osaka University Hospital, Yamadaoka 2-15, Suita, Osaka 565-0871, Japan.
  • Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Yamadaoka 1-7 Suita, Osaka 565-0871, Japan. Electronic address: nabe@sahs.med.osaka-u.ac.jp.

Förderung

  • JSPS

Zitieren

APA

Ohtani, H., Inoue, N., Iwatani, Y., Takeno, Y., Arakawa, Y., Hidaka, Y., & Watanabe, M. (2024). Effect of DNA methylation at the CTLA4 gene on the clinical status of autoimmune thyroid diseases. Clinical Immunology. https://doi.org/10.1016/j.clim.2024.110338

Vancouver

Ohtani H, Inoue N, Iwatani Y, Takeno Y, Arakawa Y, Hidaka Y, et al. Effect of DNA methylation at the CTLA4 gene on the clinical status of autoimmune thyroid diseases. Clinical Immunology. 2024. doi:10.1016/j.clim.2024.110338

BibTeX
@article{Ohtani2024,
  author = {Ohtani, Hiroki and Inoue, Naoya and Iwatani, Yoshinori and Takeno, Yuri and Arakawa, Yuya and Hidaka, Yoh and Watanabe, Mikio},
  title = {Effect of DNA methylation at the CTLA4 gene on the clinical status of autoimmune thyroid diseases},
  journal = {Clinical Immunology},
  year = {2024},
  doi = {10.1016/j.clim.2024.110338}
}
Kostenlos starten →